Vishuo Biomedical is a Singapore based healthcare technology company dedicated to establish personalized medicine for prognosis, diagnosis and treatment. It delivers genomic sequence analysis to research institutes, health screening clinics, hospitals and pharmaceutical industry. Since 2012, our products and services have been dominating the biomedical market in China. The iCMDB platform has been applied to multiple grade 3 and first-tier hospitals. Our analysis workflow was further reinforced through establishing sequencing facilities in these collaborating hospitals. In 2014, iCMDB was certified by ISO13485:2003, and classified as Class A medical device by Singapore HSA.